Jianjun Peng
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
Papers in
-
- Circular RNAs in diseases 6
- RNA modifications and cancer 5
-
- Gastric Cancer Management and Outcomes 11
- Co-authors
- Yulong He (25 shared papers)Jianbo Xu (14 shared papers)Hui Gao (7 shared papers)Xinde Ou (5 shared papers)Jinning Ye (12 shared papers)Zirui Zhao (3 shared papers)Shirong Cai (13 shared papers)Kaiming Wu (5 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Applied Sciences (2 papers)Journal of Cancer (2 papers)International Journal of Molecular Sciences (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesBrazil
In The Last Decade
Jianjun Peng
77 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 108
- Cancer Research 492
- Oncology 292
- Molecular Biology 644
- Pulmonary and Respiratory Medicine 233
- Immunology 145
Countries citing papers authored by Jianjun Peng
This map shows the geographic impact of Jianjun Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun Peng more than expected).
Fields of papers citing papers by Jianjun Peng
This network shows the impact of papers produced by Jianjun Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun Peng. The network helps show where Jianjun Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Jianjun Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 151 | |
| 2 | 2022 | 103 | |
| 3 | 2016 | 90 | |
| 4 | 2022 | 75 | |
| 5 | 2013 | 64 | |
| 6 | 2014 | 63 | |
| 7 | 2018 | 59 | |
| 8 | 2015 | 55 | |
| 9 | 2020 | 53 | |
| 10 | 2014 | 48 | |
| 11 | 2018 | 47 | |
| 12 | 2020 | 44 | |
| 13 | 2020 | 43 | |
| 14 | 2016 | 41 | |
| 15 | 2015 | 36 | |
| 16 | 2017 | 28 | |
| 17 | Alpinumisoflavone induces apoptosis in esophageal squamous cell carcinoma by modulating miR-370/PIM1 signaling. | 2016 | 26 |
| 18 | 2012 | 25 | |
| 19 | 2018 | 25 | |
| 20 | 2022 | 25 |
About Jianjun Peng
Jianjun Peng is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 84 papers that have together received 1.5k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (11 papers), Cancer Mechanisms and Therapy (6 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (6 papers), MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Wildlife Ecology and Conservation (3 papers). The work is most often cited by research in Cancer Research (492 citations), Oncology (292 citations), Molecular Biology (644 citations), Pulmonary and Respiratory Medicine (233 citations) and Immunology (145 citations). Jianjun Peng has collaborated with scholars based in China, United States and Brazil. Frequent co-authors include Yulong He, Jianbo Xu, Hui Gao, Xinde Ou, Jinning Ye, Zirui Zhao, Shirong Cai, Kaiming Wu, Haohan Liu and Weigang Dai. Their work appears in journals such as Journal of Clinical Oncology, Applied Sciences, Journal of Cancer, International Journal of Molecular Sciences and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.